Last updated on May 2019

A study to evaluate the efficacy and safety of E2609 in individuals with early Alzheimer's disease

Brief description of study

The MISSION-AD study is investigating the efficacy and safety of an investigational drug on symptoms of cognitive decline in individuals with mild cognitive impairment or early Alzheimer's disease. The study drug is a tablet which is taken by mouth once per day. The study will last approximately two years.

Eligibility Criteria:

-Attend study visits at Sharp Mesa Vista Hospital's Clinical Research Center
-Have a caregiver (spouse, relative or health care aide) who can accompany you to study visits and help monitor your study progress
-Be 55 to 85 years of age

Other Details:

Participants are reimbursed for time and travel

Clinical Study Identifier: TX133660

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.